SCN5A and atrial fibrillation: Genetic analysis may not be useful for risk stratification in Brugada syndrome as presence of SCN5A mutations in Brugada syndrome do not predict higher risk of VF [12] or AF [4] when compared to Brugada syndrome patients without these mutations.